Team KeViRx is thrilled to attend the BARDA Innovation Symposium on November 6, 2024 in Washington, DC! We are looking forward to learning about early-stage health security innovations and networking with innovators, funders, and industry partners. For details, visit: https://lnkd.in/e_q8pEpF
KeViRx, Inc.
生物技术研究
Charlottesville，VA 242 位关注者
Preclinical stage pharmaceutical company developing small molecule drugs for microvascular leakage and inflammation.
关于我们
KeViRx, Inc. is a preclinical stage pharmaceutical company headquartered in Charlottesville, VA. We are developing small molecules drugs that treat microvascular leakage and inflammation, pathologies that are the basis for many diseases, including cancer and respiratory disease. We are now entering IND-enabling studies for pulmonary microvascular leakage and inflammation during acute lung injury. Our lead asset, KVX-053 has potent anti-inflammatory and immunomodulatory effects. In preclinical models, KVX-053 reduces lung injury scoring & the biomarkers of lung injury, inflammation & proinflammatory cytokine release, & immune cell infiltration into the lung. KVX-053 also improves lung function after lung injury. Contact us for more information at [email protected].
- 网站
-
https://kevirx.com
KeViRx, Inc.的外部链接
- 所属行业
- 生物技术研究
- 规模
- 2-10 人
- 总部
- Charlottesville，VA
- 类型
- 私人持股
- 创立
- 2016
地点
-
主要
获取路线
US，VA，Charlottesville，22904
KeViRx, Inc.员工
动态
-
Honored to be part of the 2025 class of SLAS Fellows! For more details see: https://lnkd.in/eVQW2F2j
SLAS Fellow Member Program
slas.org
-
Team KeViRx is looking forward to connecting at the Wilson Sonsini Biotech Summit in Boston, MA! Hope to see you and talk to you there! https://lnkd.in/eaw8scVR
Biotech Home
https://biotech.wsgrevents.com
-
Check out the latest press release from Activation Capital featuring their Frontier BioHealth program! Meet the cohort of 10 selected startups for the inaugural program. KeViRx is excited to be part of this group! Learn more here: https://lnkd.in/gaZjintK
Activation Capital Selects 10 Startups for Inaugural Frontier BioHealth Program - Activation Capital
https://activation.capital
-
Check out our latest manuscript published in JPET! ?? Congratulations to our collaborators at Old Dominion University - Pavel Solopov, Ruben Biancatelli, Tierney Day, Betsy Gregory, and John Catravas - for their fabulous work! ?? Link to the manuscript: [Read more here](https://lnkd.in/ewKdENNf) ?? #JPET #OldDominionUniversity #KeViRx
-
Team KeViRx is very excited to be part of Activation Capital's Frontier BioHealth program! We are honored to learn with, and from, such a talented group of biotech founders! See link for details! https://lnkd.in/eR2vuwMX #FrontierBioHealth #ActivationCapital
?? What an amazing start to Frontier BioHealth! Last Thursday and Friday, we kicked off an incredible journey with our inaugural cohort of 10 groundbreaking startups, poised to revolutionize life sciences innovation. The kickoff event was hosted at the VA Bio+Tech Park, providing the perfect backdrop for this exciting launch. Meet our cohort: Atticus Pharma, GenAssist, Gisens Biotech, KeViRx, Inc., Light Switch Bio, Oncoustics, OrthoPreserve, Pele Therapeutics, Rapid Forensic Cell Typing, Inc, and Vizma.AI. A special thank you to our national partners,?gener8tor, Fat Robin, and FedTech for their invaluable support and collaboration. We also want to express our gratitude to our guest speakers and everyone who joined us—your energy and ideas are shaping the future of health. Here’s to new beginnings and groundbreaking discoveries! ?? If you're interested in learning more about the program or mentoring opportunities, please visit: https://lnkd.in/eWRg5Csq Funded [in part] through a Grant with the U.S. Small Business Administration. #FrontierBioHealth #ActivationCapital #VABioTechPark #InnovationEcosystem #Innovation #Entrepreneurship #Startups #LifeSciences #Healthcare #Pharmaceutical #BioTech #MedicalDevice
-
-
Some super exciting news! JLABS-DC hit their 3rd anniversary and several JLABS-DC resident companies recently acquired more funding! Sounds like a major boost for innovation in healthcare and biotech. Here's to continued success and breakthroughs! Learn more at: https://lnkd.in/gEz7H3gE
Growth of Early-Stage Resident Companies Marks the Third Anniversary of Johnson &Johnson Innovation – JLABS @ Washington, DC | BioBuzz
https://biobuzz.io
-
Team KeViRx is looking forward to the 2024 FASEB Protein Phosphatase meeting in Palm Springs, CA (Dec 8 -12, 2024)! Hope to see and meet you there! https://lnkd.in/eSY784Cj
-
Team KeViRx (www.KeViRx.com) is thrilled to announce the awarding of $1.99 million in non-dilutional grant funding! This funding achievement marks a significant milestone for KeViRx and will help propel its lead asset, KVX-053, closer to the clinic for pulmonary microvascular leakage and inflammation during acute lung injury. Learn more about this achievement here: https://lnkd.in/eZeMfCmD.
KeViRx, Inc. Awarded $1.99 Million
newswire.com
-
Getting ready for day 2 of the 2024 VADDC meeting in Virginia Beach, VA! Excited to hear insights from a lineup of distinguished speakers including Drs. Stephanie Davis, Umesh Desai, Skip Garcia, John Lazo, Sadis Matalon, Jetze Tepe, Shanta Hinton, Robert Gourdie, and Jessica Gilbertie! Anticipating great poster talks and networking opportunities! Learn more here: https://vaddc.org/
Virginia Drug Discovery Consortium
https://vaddc.org